Revenues from Patterson Veterinary surged 77% to $361.8 million. Revenues from Consumable veterinary sales dipped 0.5% to $190.2 million, but Veterinary equipment sales rose 24.0% to $11.5 million. Revenues from Patterson Medical were essentially flat compared with the prior year, after accounting for the planned divestiture of non-core product lines in the fiscal first quarter as part of the restructuring of the division. Share Repurchase In March, Patterson Companies raised its quarterly dividend rate by 25% to 20 cents per share. Patterson paid $20.3 million in cash dividends to shareholders in the quarter. The company has repurchased roughly 1.2 million shares for $49 million in the quarter. For the full fiscal year, Patterson Companies repurchased approximately 2.4 million shares of its outstanding common stock, leaving approximately 22 million shares for repurchase under the current authorization.